176 related articles for article (PubMed ID: 38070913)
1. Potential drug-drug interaction and its determinants among patients with cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an institutional-based cross-sectional study.
Wondm SA; Tamene FB; Gubae K; Dagnew SB; Worku AA; Belachew EA
BMJ Open; 2023 Dec; 13(12):e077863. PubMed ID: 38070913
[TBL] [Abstract][Full Text] [Related]
2. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy.
Ismail M; Khan S; Khan F; Noor S; Sajid H; Yar S; Rasheed I
BMC Cancer; 2020 Apr; 20(1):335. PubMed ID: 32307008
[TBL] [Abstract][Full Text] [Related]
4. Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis.
Dornquast C; Dombrowski M; Zabel M; Willich SN; Reinhold T
BMC Health Serv Res; 2020 Mar; 20(1):271. PubMed ID: 32234046
[TBL] [Abstract][Full Text] [Related]
5. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
[TBL] [Abstract][Full Text] [Related]
6. Potential drug-drug interactions and associated factors among admitted patients with psychiatric disorders at selected hospitals in Northwest Ethiopia.
Dagnew EM; Ergena AE; Wondm SA; Sendekie AK
BMC Pharmacol Toxicol; 2022 Nov; 23(1):88. PubMed ID: 36447276
[TBL] [Abstract][Full Text] [Related]
7. Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases.
Hecker M; Frahm N; Bachmann P; Debus JL; Haker MC; Mashhadiakbar P; Langhorst SE; Baldt J; Streckenbach B; Heidler F; Zettl UK
Front Pharmacol; 2022; 13():946351. PubMed ID: 36034780
[No Abstract] [Full Text] [Related]
8. Review of prescription medications in home-based older adults with stroke: a pilot study.
Classen S; Meuleman J; Garvan C; Ried LD; Mann W; Asal N
Res Social Adm Pharm; 2007 Mar; 3(1):104-22. PubMed ID: 17350560
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan.
Nusair MB; Al-Azzam SI; Arabyat RM; Amawi HA; Alzoubi KH; Rabah AA
Saudi Pharm J; 2020 Feb; 28(2):155-160. PubMed ID: 32042253
[TBL] [Abstract][Full Text] [Related]
11. Adequacy of cancer-related pain management using the Pain Management Index among patients with cancer in the Northwest oncology centres of Ethiopia: an institutional-based cross-sectional study.
Mihiretie EA; Siyum TS; Tamene FB
BMJ Open; 2024 Feb; 14(2):e081744. PubMed ID: 38331858
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
Shouqair TM; Rabbani SA; Sridhar SB; Kurian MT
Cureus; 2022 Apr; 14(4):e24019. PubMed ID: 35573572
[TBL] [Abstract][Full Text] [Related]
13. Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.
Khanna J; Kumar S; Mehta S; Chaudhary J; Jain A
J Pharm Technol; 2024 Jun; 40(3):142-151. PubMed ID: 38784027
[No Abstract] [Full Text] [Related]
14. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
[TBL] [Abstract][Full Text] [Related]
15. Potential drug-drug interactions in older adults: A population-based study.
Santos TRA; Silveira EA; Pereira LV; Provin MP; Lima DM; Amaral RG
Geriatr Gerontol Int; 2017 Dec; 17(12):2336-2346. PubMed ID: 28635169
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
[TBL] [Abstract][Full Text] [Related]
17. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.
Feinstein J; Dai D; Zhong W; Freedman J; Feudtner C
Pediatrics; 2015 Jan; 135(1):e99-108. PubMed ID: 25511114
[TBL] [Abstract][Full Text] [Related]
18. Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Noor S; Ismail M; Haider I; Khadim F
Ann Hepatol; 2018 Oct; 17(6):1001-1011. PubMed ID: 30600298
[TBL] [Abstract][Full Text] [Related]
19. Nationwide prevalence of potential drug-drug interactions associated with non-anticancer agents in patients on oral anticancer agents in South Korea.
Song YK; Oh JM
Support Care Cancer; 2020 Aug; 28(8):3711-3720. PubMed ID: 31820128
[TBL] [Abstract][Full Text] [Related]
20. Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis.
Debus JL; Bachmann P; Frahm N; Mashhadiakbar P; Langhorst SE; Streckenbach B; Baldt J; Heidler F; Hecker M; Zettl UK
Ther Adv Chronic Dis; 2022; 13():20406223221108391. PubMed ID: 35959503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]